https://www.selleckchem.com/pr....oducts/cucurbitacin-
039). Multivariate analysis found that SCLNs metastasis was an independent risk factor affecting the prognosis of ESCC in the middle and lower thoracic segments (P=0.007). Conclusions For patients with upper thoracic ESCC, SCLNs appear to be regional nodes. For the middle and lower thoracic ESCC, SCLNs should be defined as distant metastasis, and neoadjuvant therapy first may be an available therapy. 2020 Annals of Translational Medicine. All rights reserved.Background DNA topoisomerase enzyme plays an essential role in controlli
Like
Comment
Share
